International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct

Sheela Rao*, Francesco Sclafani, Cathy Eng, Richard A. Adams, Marianne G. Guren, David Sebag-Montefiore, Al Benson, Annette Bryant, Clare Peckitt, Eva Segelov, Amitesh Roy, Matt T. Seymour, Jack Welch, Mark P. Saunders, Rebecca Muirhead, Peter O’Dwyer, John Bridgewater, Shree Bhide, Rob Glynne-Jones, Dirk ArnoldDavid Cunningham

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint Dive into the research topics of 'International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct'. Together they form a unique fingerprint.

Medicine & Life Sciences